CVE-2026-24005Kruise provides automated management of large-scale applications on Kubernetes.
Updated under an hour ago ()
Does this affect you?
It affects openkruise kruise. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Kruise provides automated management of large-scale applications on Kubernetes. Prior to versions 1.8.3 and 1.7.5, PodProbeMarker allows defining custom probes with TCPSocket or HTTPGet handlers. The webhook validation does not restrict the Host field in these probe configurations. Since kruise-daemon runs with hostNetwork=true, it executes probes from the node network namespace. An attacker with PodProbeMarker creation permission can specify arbitrary Host values to trigger SSRF from the node, perform port scanning, and receive response feedback through NodePodProbe status messages. Versions 1.8.3 and 1.7.5 patch the issue.
- CVSS
- 7.6 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:L
- Weakness (CWE)
- CWE-918
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
openkruise kruise openkruise:kruise | before 1.7.5; from 1.8.0 before 1.8.3 | NVD |
References
- https://github.com/openkruise/kruise/commit/94364b76adf3e8a1749a31afe809a163bed29613patch
- https://github.com/openkruise/kruise/releases/tag/v1.7.5product, release-notes
- https://github.com/openkruise/kruise/releases/tag/v1.8.3product, release-notes
- https://github.com/openkruise/kruise/security/advisories/GHSA-9fj4-3849-rv9gexploit, mitigation, vendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.